Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

CUSIP: 03843E104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
120,192,308
Total 13F shares
15,624,060
Share change
-1,222,064
Total reported value
$62,031,877
Put/Call ratio
117%
Price per share
$3.97
Number of holders
56
Value change
-$6,395,474
Number of buys
29
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bratton Capital Management, L.P.
13F
Company
8.2%
9,810,958
$51,017,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
1.1%
1,356,400
$7,054,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
0.71%
856,426
$4,453,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.64%
764,217
$3,974,000 31 Mar 2021
13F
Bracebridge Capital, LLC
13F
Company
0.36%
428,571
$2,229,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
0.3%
358,042
$1,862,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.3%
354,856
$1,845,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
0.27%
323,643
$1,683,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.18%
212,402
$1,104,000 31 Mar 2021
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.17%
207,609
$1,080,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.14%
172,697
$899,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.14%
164,234
$854,000 31 Mar 2021
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
152,000
$790,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.12%
141,392
$735,000 31 Mar 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.12%
138,382
$720,000 31 Mar 2021
13F
Brandywine Global Investment Management, LLC
13F
Company
0.11%
136,116
$708,000 31 Mar 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.11%
129,873
$675,000 31 Mar 2021
13F
IndexIQ Advisors LLC
13F
Company
0.07%
89,390
$465,000 31 Mar 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.06%
75,463
$392,000 31 Mar 2021
13F
HighTower Advisors, LLC
13F
Company
0.06%
68,617
$357,000 31 Mar 2021
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.05%
54,495
$283,000 31 Mar 2021
13F
Engineers Gate Manager LP
13F
Company
0.04%
51,200
$266,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
46,826
$243,000 31 Mar 2021
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
41,300
$215,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
37,879
$197,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
37,069
$193,000 31 Mar 2021
13F
DUPONT CAPITAL MANAGEMENT CORP
13F
Company
0.03%
36,752
$191,000 31 Mar 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
29,960
$156,000 31 Mar 2021
13F
GROUP ONE TRADING LLC
13F
Company
0.02%
25,989
$135,000 31 Mar 2021
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.02%
19,786
$103,000 31 Mar 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
18,815
$98,000 31 Mar 2021
13F
Geneos Wealth Management Inc.
13F
Company
0.02%
23,300
$94,000 31 Mar 2021
13F
BARCLAYS PLC
13F
Company
0.01%
16,612
$86,000 31 Mar 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
15,800
$82,000 31 Mar 2021
13F
Oak Grove Capital LLC
13F
Company
0.01%
15,500
$81,000 31 Mar 2021
13F
UBS Group AG
13F
Company
0.01%
14,174
$74,000 31 Mar 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
14,132
$73,000 31 Mar 2021
13F
CWA Asset Management Group, LLC
13F
Company
0.01%
13,811
$72,000 31 Mar 2021
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
13,360
$69,000 31 Mar 2021
13F
Financial Advocates Investment Management
13F
Company
0.01%
13,000
$68,000 31 Mar 2021
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.01%
12,689
$66,000 31 Mar 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
12,014
$62,000 31 Mar 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
11,581
$60,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
0.01%
11,557
$60,000 31 Mar 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.01%
11,200
$58,000 31 Mar 2021
13F
XTX Topco Ltd
13F
Company
0.01%
10,970
$57,000 31 Mar 2021
13F
Trexquant Investment LP
13F
Company
0.01%
10,227
$53,000 31 Mar 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.01%
10,040
$52,000 31 Mar 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
10,000
$52,000 31 Mar 2021
13F
WEDBUSH SECURITIES INC
13F
Company
0.01%
10,000
$52,000 31 Mar 2021
13F

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2021

As of 30 Jun 2021, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,624,060 shares. The largest 10 holders included Bratton Capital Management, L.P., VANGUARD GROUP INC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Bracebridge Capital, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Latash Investments, LLC, GEODE CAPITAL MANAGEMENT, LLC, and CAAS CAPITAL MANAGEMENT LP. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
62
Q2 2021 holders
56
Holder diff
-6
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .